Linked Life Data

21651424

Source:http://linkedlifedata.com/resource/pubmed/id/21651424

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
8
pubmed:dateCreated
2011-7-15
pubmed:abstractText
Angiogenesis inhibitors targeting the vascular endothelial growth factor (VEGF) signalling pathways have demonstrated therapeutic efficacy in a wide variety of malignancies. With their increased use, adverse events, some common and certain rare but characteristic complications, are being recognized. The exact mechanisms for the development of at least some of these side effects are not entirely clear.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
1473-4877
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
27
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1503-7
pubmed:meshHeading
pubmed:year
2011
pubmed:articleTitle
Nitric oxide and adverse events of vascular endothelial growth factor inhibitors.
pubmed:affiliation
Department of Haematology, University of Liverpool, Liverpool, UK. jeckothachil@yahoo.co.uk
pubmed:publicationType
Journal Article, Review